Syringic Acid ameliorates Bleomycin induced Pulmonary Inflammation and Fibrosis in rats via maintenance of endogenous anti-oxidants and downregulation of pro-inflammatory markers
Lakshmi BVS,
krupavaram bethala
Abstract:Background: Chronic administration of bleomycin (BLM), a chemotherapeutic drug, has been linked to idiopathic pulmonary fibrosis (IPF). It has been observed that syringic acid, a phenolic compound, has antiapoptotic, anti-inflammatory, and antioxidant properties. To assess syringic acid's therapeutic potential against lung fibrosis caused by BLM and determine a potential mechanism of action.
Methods: Sprague-Dawley rats were inducted into IPF after receiving 7.5 IU/kg of BLM intratracheally. Syringic acid (50 … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.